Medivir to present at the Stockholm Corporate Finance Life Science Seminar on March 13
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Stockholm Corporate Finance 11th Life Science Seminar in Stockholm. The presentation will take place at 9am on Wednesday, March 13, 2019. Dr. Uli Hacksell, CEO of Medivir, will present the latest development and the company´s future. The presentation will be streamed live via Medivirs website; www.medivir.com, or by following the link; https://financialhearings.com/event/11531 For further information, please contact:Uli Hacksell, CEO, Medivir AB, mobile: +46 (08) 5468 3100.